46Brooklyn Spotlights Part D Feature That Favors Brands Over Generics

By John Wilkerson / August 13, 2020 at 12:32 PM

A new report uses a decades-old brand-name drug to expose a feature in Medicare Part D that could undermine generic competition for specialty drugs.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.